That’s one way that Chiesi Group – an Italian family business-turned-global pharma company – seeks to define itself. A Benefit Corporation since 2018 and a Certified B-Corp since 2019 ...
Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. in an all-cash transaction at $14.50 per American Depositary Share (ADS). Each ADS ...
DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the previously announced acquisition of Muscoril® New brand identity ...
Clearside Biomedical (CLSD) reported that Arctic Vision’s New Drug Application or NDA for arcatus for the treatment of uveitic macular edema ...
The Company had approximately $98.8 million in cash and cash equivalents as of December 31, 2024. Net cash used in operating activities was approximately $60.9 million, compared to $102.0 million ...
In a report released on February 14, Christophe dombu from Kepler Capital maintained a Buy rating on Hyloris Pharmaceuticals SA (52U – Research Report), with a price target of €16.00.
Perform material- and labor-effective extrusion with Thermo Scientificâ„¢ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...
The mouse on the right with four times the normal muscle mass is placed with a normal mouse. Handout via REUTERS About a dozen drugmakers are developing new weight-loss treatments aimed at ...
On Tuesday, Recursion Pharmaceuticals stock reached a key performance benchmark, with its Relative Strength (RS) Rating rising into the 90-plus percentile with an improvement to 92, a rise from 64 ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States after an investigation found the devices operate as intended. J&J resumes ...
IPC Indice de Precios Y Cotizaciones 54,476.74 185.10 0.34% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results